JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.
As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF’s expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization’s efficiency and effectiveness.
Less Until None
JDRF is the only global organization with a strategic plan to bring those living with T1D a continuous flow of life-changing therapies and, ultimately, a cure for the disease.
JDRF’s highest priority remains funding research to deliver a cure for T1D and its complications. At the same time, JDRF is also focused on developing better treatments that will transform the way people with T1D treat the disease today, in order to help them live healthier lives now and in the future. Finally, JDRF also seeks to prevent T1D, to keep future generations from developing the disease.
This is all part of JDRF’s promise of “less until none”: to progressively remove the impact of T1D from the lives of those living with the disease until it is no longer a threat to them or their families.
Innovation and Collaboration
JDRF-funded research has led to many landmark advances in T1D science. JDRF is now in the exciting position of taking that research knowledge and translating it into real therapies that will make life-changing differences for those facing the daily challenges of T1D. Currently, JDRF is funding more than 50 human clinical trials, several of which are in the advanced stages of clinical testing needed before FDA approvals can be sought.
JDRF’s influence and leadership extends beyond funding research. We strategically partner with industry, governments, foundations, academia, healthcare insurers, and clinicians to ensure that JDRF and its partners are aligned and working toward a common goal of a world without T1D.
JDRF’s advocacy efforts help support a variety of issues that are critical to JDRF achieving its research objectives. Our focus includes increased government funding for T1D research and a regulatory environment that allows people with T1D to benefit from potential new therapies and devices as quickly and safely as possible. Finally, JDRF’s outreach efforts provide practical support and resources for people with T1D and their families every step of the way as they live with T1D.
JDRF has always been dedicated to maintaining the highest levels of efficiency to ensure that our time, resources, and dollars can achieve the greatest possible impact on the lives of people with T1D. We have a solid track record of funding research efficiently and effectively. More than 80 percent of what JDRF spends goes directly to research and research-related education—among the highest percentages for charities nationwide.
JDRF was created—and is still led—by people with a personal connection to T1D. Today, volunteers at JDRF’s more than 100 locations worldwide remain the driving force behind our activities. That gives us an unrelenting passion and commitment to work to remove the impact of T1D from people’s lives. Whether it’s providing funding for a late-stage clinical trial, advocating faster regulatory approval of new devices, or partnering with a company on research that might not otherwise receive funding, every decision JDRF makes is driven by our commitment to achieving a world without T1D.